Quality Control, Screening, Toxicity, and Regulation of Herbal Drugs

Modern Phytomedicine: Turning Medicinal Plants into Drugs

Volumn , Issue , 2006, Pages 25-57

  Bandaranayake, Wickramasinghe M ^a  

^a AUSTRALIAN INSTITUTE OF MARINE SCIENCE   (Australia)

Author keywords

Adulteration of herbal drugs; Herbal supplements; Labeling of herbal products; Modern phytomedicine; Preparation of herbal drugs; Quality control; Regulation of herbal drugs; Screening; Toxicity

Indexed keywords

EID: 84889791830     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527609987.ch2     Document Type: Chapter

References (154)

1. Solecki, R.S., Shanidar IV, Science 1975, 190, 880.
2. Bensky, D., Gamble, A. Chinese Herbal Medicine: Materia Medica. Eastland Press, Seattle, 1993.
3. Cassileth, B.R. The Alternative Medicine Handbook. W.W. Norton and Co., New York, 1998.
4. Lans, C. Harper, T. Georges K., Bridgewater, E. BMC Complement. Altern. Med. 2001, 10, 1
5. Cragg, G.M., Newman. D.J. Ann. NY Acad. Sci. 2001, 953, 3.
6. Ackerknecht, E.H. Therapeutics: from the Primitives to the Twentieth Century. Hafner Press, New York, 1973.
7. Majno, G.M. Healing Hand: Man and Wound in the Ancient World. Harvard University Press, Cambridge, MA, 1975.
8. Farnsworth, N.R., Morris, R.W. Am. J. Pharm. Educ. 1976, 148, 46.
9. Duke, J.A., Martinez, R.V. Handbook of Ethnobotanicals (Peru). CRC Press, Boca Raton, FL, 1994.
10. De Smet, P.A.G.M. Drug Safety 1995, 13, 81.
11. Cragg, G.M. Newman, D.J. Snader, K.M. J. Nat. Prod. 1997, 60, 52.
12. Shu. Y.Z. J. Nat. Prod. 1998, 61, 1053.
13. Liu, Z., Liu, Y. J. Herbal Phytother. 2001, 1, 25.
14. WHO. The International Pharmacopeia, Vol. 1: General Methods of Analysis, 3rd edn. World Health Organization, Geneva, 1979.
15. WHO. The International Pharmacopeia, Vol. 2: Quality Specifications, 3rd edn. World Health Organization, Geneva, 1981.
16. WHO. The Use of Essential Drugs. Eighth report of the WHO Expert committee. World Health Organization, Geneva, 1990.
17. WHO. Quality Control Methods for Medicinal Plant Materials, World Health Organization, Geneva, 1998.
18. WHO. Guidelines for the Appropriate Use of Herbal Medicines. WHO Regional Publications, Western Pacific Series No 3, WHO Regional office for the Western Pacific, Manila, 1998.
19. WHO. Quality Control Methods for Medicinal Plant Materials. World Health Organization, Geneva, 1999.
20. WHO. WHO Monographs on Selected Medicinal Plants, Vol. 1, World Health Organization, Geneva, 1999.
21. WHO. WHO Monographs on Selected Medicinal Plants, Vol. 2, World Health Organization, Geneva, 2002.
22. WHO. Ancient Remedies, New Disease. World Health Organization, Geneva, 2002.
23. WHO. WHO Global Atlas of Traditional, Complementary and Alternative Medicine. 2 vol. set. Vol. 1 contains text and Vol. 2, maps. World Health Organization, Geneva, 2005.
24. Akerele, O. HerbalGram. 1993, 28, 13.
25. Bisset, N.G. (ed.). Herbal Drugs and Phytopharmaceuticals. CRC Press, Boca Raton, FL, 1994.
26. Calixto, J. B. Braz. J. Med. Biol. Res. 2000, 33, 179.
27. Pal, S.K., Shukla, Y. Asian J. Cancer Prev. 2003, 4, 281.
28. Farnsworth, N.R., Akerele, O., Bingel, A.S., Soejarto, D.D., Guo, Z. World Health Organ. 1985, 63, 965.
29. Mukherjee, P.W. Quality Control of Herbal Drugs: An Approach to Evaluation of Botanicals. Business Horizons Publishers, New Delhi, India, 2002.
30. Bodeker, C., Bodeker, G., Ong, C.K., Grundy, C.K., Burford, G., Shein, K. WHO Global Atlas of Traditional, Complementary and Alternative Medicine. World Health Organization, Geneva, 2005.
31. Kong, J.M., Goh, N.K., Chia, L.S., Chia, T.F. Acta Pharm. Sinic. 2003, 24, 7.
32. De Smet, P. A. G. M. Drugs, 1997, 54, 801.
33. Blumenthal, M. HerbalGram 1999, 45, 68.
34. Grunwald, J. HerbalGram 1995, 34, 60.
35. Roberts, J.E., Tyler, V.E. Tyler's Herbs of Choice. The Therapeutic Use of Phytomedicinals. The Haworth Press, New York, 1997.
36. Blumenthal, M., Brusse, W.R., Goldberg, A., Gruenwald, J., Hall, T., Riggins, C. W., Rister, R.S. The Complete German Commission E Monographs. Therapeutic Guide to Herbal Medicines. The American Botanical Council, Austin, TX, 1998.
37. Midley, J.M. Pharm. J. 1988, 241, 358.
38. Bauer, R., Tittel, G. Phytomedicine. 1996, 2, 193.
39. Baur, R. Drug Inf. J. 1998, 32, 101.
40. Schier, W., Sachsa, B., Schultze, W. Dtsch Apoth. Ztg. 1994, 134, 4569.
41. WHO. The International Pharmacopeia, Vol. 3: Quality Specifications for Pharmaceutical Substances, Excipients, and Dosage Forms, 3rd edn. World Health Organization, Geneva, 1988.
42. WHO. Basic Tests for Drugs, Pharmaceutical Substances, Medicinal Plant Materials and Dosage Forms. World Health Organization, Geneva, 1998.
43. WHO. Quality Assurance of Pharmaceuticals: A Compendum of Guidelines and Related Materials, Vol. 2: Good Manufacturing Practices and Inspection. World Health Organization, Geneva, 1996.
44. WHO. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. World Health Organization, Geneva, 2002.
45. EMEA. Guidelines on Quality of Herbal Medicinal Products/Traditional Medicinal Products, EMEA/CVMP/814OO Review. European Agency for the Evaluation of Medicinal Products (EMEA), London, 2005.
46. EMEA. Quality of Herbal Medicinal Products. Guidelines. European Agency for the Evaluation of Medicinal Products (EMEA), London, 1998.
47. WHO. Quality Control Methods for Medicinal Plant Materials. World Health Organization, Geneva, 1992.
48. De Smet. P.A.G.M. Drug Inf. J. 1999, 33, 717.
49. Hsu, C.K., Leo, P., Shastry, D., Meggs, W., Weisman, R., Hoffman, R.S. Arch. Intern. Med. 1995, 155, 2245.
50. WHO. Guidelines for the Assessment of Herbal Medicines. WHO Technical Report Series, No 863. World Health Organization, Geneva, 1996.
51. Watson, D.G. Pharmaceutical Analysis. Churchill Livingstone, Edinburgh, 1999.
52. WHO. Quality Control Methods for Medicinal Plant Materials. World Health Organization, Geneva, 1988.
53. WHO. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. World Health Organization, Geneva, 2000.
54. WHO. WHO Guidelines on Good Agricultural and Collection Practices (GACP). World Health Organization, Geneva, 2003.
55. WHO. Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants. World Health Organization, Geneva, 2004.
56. EMEA. Points to Consider on Good Agricultural and Collection Practice for Starting Materials of Herbal Origin. EMEA/HMPWP/31/99 Review. European Agency for the Evaluation of Medicinal Products (EMEA), London, 2002.
57. Eskinazi, D., Blumenthal, M., Farnsworth, N., Riggins, C.W. Botanical Medicine: Efficacy, Quality, Assurance, and Regulation. Mary Ann Liebert, New York, 1999.
58. Keller, K. Drug Inf. J. 1996, 30, 933.
59. Li, F., Sun, S., Wang, J., Wang, D. Biomed. Chromatogr. 1998, 12, 78.
60. AOAC. Official Methods of Analysis of AOAC International, 18th edn. AOAC International, Gaithersburg, MD, 2005.
61. De Smet, P.A.G.M., Keller, K. Hansel, R., Chandler, R.F. Adverse Effects of Herbal Drugs, Vol. 1. Springer-Verlag, Heidelberg, 1992.
62. Lazarowych, N., Pekos. P. Drug Inf. J. 1998, 32, 497.
63. Sarmani, S. B., Abugassa, I., Hamzah, A., Yahya, M.D. Biol. Trace Elem. Res. 1999, 71-72, 365.
64. Boumans, P.W.J.M. Inductively Coupled Plasma-emission Spectroscopy Part 1. John Wiley & Sons, New York, 1999.
65. WHO. The WHO Recommended Classification of Pesticides by Hazard and Guidelines to Classification 2000-2202 (WHO/PCS/01.5). International Programme on Chemical Safety, World Health Organization, Geneva, 2000.
66. Anonymous. European Pharmacopoeia, 3rd edn. Strasbourg Council of Europe, 1996.
67. Farber, J.M., Carter, A.O., Varughese, P.V., Ashton, F.E., Ewan, E.P. New Engl. J. Med. 1990, 322, 338.
68. Kneifel, W., Czech, E., Kopp, B Planta Med. 2002, 68, 5.
69. De Smet, P.A.G.M., in Adverse Effects of Herbal Drugs, De Smet, P.A.G.M., Keller, K., Hansel, R., Chandler, R.F. (eds), Vol. 3. Springer-Verlag, Heidelberg, 1997, p. 137.
70. De Smet, P.A.G.M., in Adverse Effects of Herbal Drugs,, De Smet, P.A.G.M., Keller, K., Hansel, R., Chandler, R.F. (eds), Vol. 3. Springer-Verlag, Heidelberg, 1997, p. 145.
71. De Smet, P.A.G.M., in Adverse Effects of Herbal Drugs,, De Smet, P.A.G.M., Keller, K., Hansel, R., Chandler, R.F. (eds), Vol. 3. Springer-Verlag, Heidelberg, 1997, p. 129.
72. Sinha, K.K. (ed.). Mycotoxins in Agriculture and Food Safety. Marcel Dekker, New York, 1998.
73. Anonymous. Deutsches Arzneibuch 2000. Deutscher Apotheker Verlag, Stuttgart, 2000.
74. Anonymous. Momoopatiscen Arzneibuch 2000. Deutscher Apotheker Verlag, Stuttgart, 2000
75. van Valkenburg, J.L.C.H., Bunyapraphatsara, N. (eds). Plant Resources of South-East Asia 12 (2): Medicinal and Poisonous Plants 2. Backhuys Publ., Leiden, 2001.
76. WHO. The International Pharmacopeia, Vol. 4: Tests Methods, and General Requirements, 3rd edn. World Health Organization, Geneva, 1988.
77. Rózylo, J.K., Zabinska, A., Matysiak, J., Niewiadomy, A. J. Chromatogr. Sci. 2002, 40, 581.
78. Bilia, A.R., Bergonzi, M.C., Lazari, D., Vincieri, F.F. J. Agric. Food Chem. 2002, 50, 5016.
79. Ebel, S., Gigalke, H.J., Voelkl, S. AMDHPTLC Analysis of Medicinal Plants. Proceedings of 4th International Symposium of Instrumental HPTLC, Selvino/Bargamo at Italy, 1987, p. 113.
80. Ko, R.J., Greenwald, M.S., Loscutoff, S.M., Au, A.M., Appel, B.R., Kreutzer, R.A., Haddon, W.F., Jackson, T.Y., Boo, F.O., Presicek, G. West. J. Med. 1996, 164, 71.
81. Farnsworth, N.R., Henry, L.K., Svoboda, G.H., Blomster, R.N., Yates, M.J., Euler, K.L. Lloydia 1966, 29, 101.
82. Farnsworth, N.R., Henry, L.K., Svoboda, G.H., Blomster, R.N., Fong, H.H.S., Quimby, M.W., Yates, M.J. Lloydia 1968, 35, 35.
83. WHO. The International Pharmacopeia, Vol. 4: Test Methods and General Requirements. Quality Specifications for Pharmaceutical Substances, Excipients, and Dosage Forms, 3rd edn. World Health Organization, Geneva, 1994.
84. WHO. The International Pharmacopeia, Vol. 2: Quality Specifications, 3rd edn. World Health Organization, Geneva, 1983.
85. The International Pharmacopeia, Vol. 4: Test Methods and General Requirements. Quality Specifications for Pharmaceutical Substances, Excipients, and Dosage Forms, 3rd edn. World Health Organization, Geneva, 1994.
86. IPCS. Pyrrolizidine alkaloids, Health and Safety Guide. Standards on Chemical Safety Health and Safety Guide No. 26. International Programme on Chemical Safety, Geneva, 1989.
87. Farnsworth, N.R., Bingel, A.S., in New Natural Products and Plant Drugs with Pharmacological, Biological or Therapeutical Activity. A.H. Wagner, P. Wolff (eds), Proceedings of the First International Congress on Medicinal Plant Research. Springer-Verlag, Berlin, Heidelberg, New York, 1977.
88. Evans, W.C. Br. J. Phytother. 1990, 1, 16.
89. Ramsay, H.M., Goddard, W., Gill, S., Moss, C. Arch. Dis. Child. 2003, 88, 1056.
90. Segasothy, M., Samad, S. Nephron 1991, 59, 199.
91. Chan, T.Y., Chan, J.C., Tomlinson, B., Critchley, J.A. Lancet 1993, 342, 1532.
92. Anonymous. Evaluation of Certain Food Additives and Contaminants. 22nd Report of the Joint FAO/WHO Expert committee on Food Additives. Technical Report Series 631. World Health Organization, Geneva, 1978.
93. Anonymous. Evaluation of Certain Food Additives and Contaminants. 33rd Report of the Joint FAO/WHO Expert committee on Food Additives. Technical Report Series 776. World Health Organization, Geneva, 1989.
94. Anonymous. Evaluation of Certain Food Additives and Contaminants. 41st Report of the Joint FAO/WHO Expert committee on Food Additives. Technical Report Series 837. World Health Organization, Geneva, 1993.
95. Ross, J.J.W., Pelders, M.G., De Smet, P.A.G.M. Pharm. World Sci. 1999, 21, 44.
96. Abt, A.B., Oh, J.Y., Huntington, R.A., Burkhart, K.K. Arch. Intern. Med. 1995, 155, 211.
97. Nelson, L., Shih, R., Hoffman, R. J. Toxicol-Clin. Toxicol. 1995, 33, 467.
98. Gertner, E., Marshall, P.S., Filandrinos, D., Potek, A.S., Smith, T.M. Arthritis Rheum. 1995, 38, 614.
99. Van der Stricht, B.I., Parvais, O.E., Vanhaelen-Fastre, R.J., Vanhaelen, M.H. BMJ 1994, 308, 1162.
100. Pitetti, R., Singh, S., Hornyak, D. Pediatr. Emerg. Care. 2001, 17, 165.
101. Herr, S.M. Herb-Drug Interaction Handbook, 3rd edn. ISBN 0967877326, 2005.
102. Barnes, J., Anderson, L.A., Phillipson, J.D. J. Pharm. Pharmacol. 2001, 53, 583.
103. Smolinske, S.C. J. Am. Med. Womens Assoc. 1999, 54, 191.
104. Fugh-Berman, A. Lancet 2000, 355, 144.
105. Meneilly, G. Top ten tips for avoiding drug-herb interactions. Living + 2000, 6. http://www.bcpwa.org/issue6/tentips.htm. Accessed January 2004.
106. Ernst, E. Eur. J. Pediatr. 2003, 162, 72.
107. Janetzky, K., Morreale, A.P. Am. J. Health Syst. Pharm. 1997, 54, 692.
108. Jowell. T. Herbal Medicines. House of Commons official report (Hansard). 1999, 26, 426.
109. Mathews, J. Holisticonline.com 1998-2005. http://www.holisticonline.com/alt_medicine/altmed_definit ions.htm. Accessed August 2005.
110. Moore, B., Adler, R. Pediatrics. 2000, 106, 600.
111. Florido-Lopez, F., Gonzalez-delgado, P., Desanpedro, B.S., Perez-Miranda, C., De Saavedra, J.M.A., Marinpozo, J.F. Int. Arch. Allergy Immun. 1995, 108, 170.
112. D'Arcy, P.F. Adverse Drug React. Toxicol. Rev. 1991, 10, 189.
113. D'Arcy, P.F. Adverse Drug React. Toxicol. Rev. 1993, 12, 147.
114. Rosenblatt, M., Mindei, J. N. Engl. J. Med. 1997, 336, 1108.
115. Pillans, P.I. N. Z. Med. J. 1995, 108, 469.
116. Winston, D., Nvwoti. in American Herbalism, Tierra, M. (ed.). The Crossing Press, Freedom, CA, 1992.
117. McRae. S. Can. Med. Assoc. J. 1996, 155, 293.
118. Marcus, D.M., Snodgrass., W.R. Obstet. Gynecol. 2005, 105, 1119.
119. Marcus, D.M., Snodgrass, W.R. Obstet. Gynecol. 2005, 106, 640.
120. Tomassoni, J., Simone, K. Curr. Opin. Pediatr. 2001, 13, 162.
121. Brinker, F. An Introduction to the Toxicology of Common Botanical Medicines. NCNM (National College of Naturopathic Medicine), Oregon, 1983. AMA. AMA Handbook of Poisonous and Injurious Plants. American Medical Association, Chicago, 1985.
122. Sharma, M.L., Chandokhe, N., Ray Ghatak, B.J., Jamwal, K.S., Gupta, O.P., Singh, G.B., Ali, M.M., Thakur, R.S., Handa, K.L., Rao, P.R., Jamwal, P.S., Sareen, Y.K. Indian J. Exp. Biol. 1978, 16, 228.
123. Aswal, B.S., Bhakuni, D.S., Goel, A.K., Kar, K., Mehrotra, B.N. Indian J. Exp. Biol. 1984, 22, 487.
124. Boyd, N.G. Princ. Pract. Oncol. 1989, 3, 1.
125. Farnsworth, N.R. HerbalGram (Special Suppl.), 1993, 29, 36A-36H.
126. Farnsworth, N.R., Loub, W.D., in Plants: the Potential for Extracting Proteins, Medicines, and Other Useful Chemicals. Workshop proceedings. OTA-BP-F-23. US Congress, Office of Technology Assessment, Washington, DC, 1983.
127. Loub, W.D., Farnsworth, N.R., Soejarto, D.D., Quinn, M.L. J. Chem. Inf. Comput. Sci. 1985, 25, 99.
128. Strosberg, A.D., Marullo, S. Trends Pharmacol. Sci. 1992, 13, 95.
129. Hobden, A.N., Harris, T.J.R. Proc. R. Soc. Edin. B. 1992, 99, 37.
130. Cragg, G.M., Boyd, M.R. Drug development at the national cancer institute, in Balick, M.J., Elisabetsky, E., Laird, S.A. (eds) Medicinal Resources of the Tropical Forest. Columbia University Press, New York, 1999.
131. Hallowell, C. Time 1997, 150, 16.
132. Poulev, A., Deus-Neumann, B., Zenk, M.H. Planta Med. 1993, 59, 442.
133. Budzinski, J.W., Foster, B.C., Vandenhoek, S., Arnason J.T. Phytomedicine 2000, 7, 273.
134. Mitscher, L.A., Telikepalli, H., Wang, PB-B, Kuo, S., Shankel, D.M.,. Stewart. S. Mutat. Res. 1992, 267, 229.
135. Williamson, N. Am. Hortic. 1995, 74.
136. Tona, L., Kambu, K., Mesia, K., Cimanga, K., Apers, S., De Bruyne, T., Pieters, L., Totte, L., Vlietinck, A.J. Phytomedicine. 1999, 6, 59.
137. Gaedcke, F., Steinhoff, B. Herbal Medicinal Products. Scientific and Regulatory Basis for Development, Quality Assurance and Marketing Authorisation. CRC Press, Boca Raton, 2003
138. Snider, S. FDA Consum. 1991, 31.
139. Drew, A., Myers, S.P., Med. J. Aust. 1997, 166, 538.
140. Wichtl, N.G., Wichtl, M. (eds). Asian J. Can. Prev. 2000.
141. Arvigo, R., Balick, M. Rainforest Remedies: 100 Healing Herbs of Belize. Lotus Press, Twin Lakes, WI, 1993.
142. Rousseaux, C.G., Schachter, H. Birth Defects Res. B: Dev. Reprod. Toxicol. 2003, 68, 505.
143. Zeisel, S.H. Science 1999, 285, 1853.
144. Petrovick, P.R., Marques, L.C., Paula, I.C., J. Ethnopharmacol. 1999, 66, 51.
145. Haden, B.L., Haden, C.R. Alternative Health Care: The Canadian Directory. Nobel Agnes Publishing, Toronto, 1997.
146. Mukherjee, P.K., Verpoorte R. (eds) GMP for Botanicals: Regulatory and Quality Issues on Phytomedicines. Business Horizons, New Delhi, 2003.
147. WHO. Legal Status of Traditional Medicine and Complementary/Alternative Medicine. World Health Organization, Geneva, 2002.
148. WHO. Bulletin of the World Health Organization. Regulatory Situation of Herbal Medicines. A Worldwide Review. World Health Organization, Geneva, 1998.
149. WHO. Regulatory Situation of Herbal Medicines: a Worldwide Review. World Health Organization, Geneva, 1998.
150. WHO. Guidelines for the Regulatory Assessment of Medicinal Products for Use in Self Medication. World Health Organization, Geneva, 2002.
151. WHO. Research Guidelines for the Safety and Efficacy of Herbal Medicines. World Health Organization, Geneva, 1993
152. Chaudhury R.R. Herbal Medicine for Human Health. SEARO, No. 20. World Health Organization, New Delhi, 1992.
153. Lueng, A. HerbalGram 2000, 48, 63.
154. Wagner, H. Natural products chemistry and phytomedicine research in the new millennium: new developments and challenges. http://www.arkat-usa.org/ark/journal/2004/I07_Antus/SA-1008R/1008R.asp. Accessed 26 September 2005, 2004.